Risk of endocarditis among patients with coagulase-negative Staphylococcus bacteremia

[1]  M. Hannan,et al.  The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Rasmussen,et al.  Risk stratification score screening for infective endocarditis in patients with Gram-positive bacteraemia , 2022, Infectious diseases.

[3]  E. Múñez-Rubio,et al.  Unreliability of Clinical Prediction Rules to Exclude without Echocardiography Infective Endocarditis in Staphylococcus aureus Bacteremia , 2022, Journal of clinical medicine.

[4]  M. Rasmussen,et al.  Time to blood culture positivity in Staphylococcus aureus bacteremia is useful to determine the risk for infective endocarditis. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  M. Rezaee,et al.  The role of the Coagulase-negative staphylococci (CoNS) in infective endocarditis; a narrative review from 2000 to 2020. , 2020, Current pharmaceutical biotechnology.

[6]  L. Køber,et al.  Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. , 2019, European heart journal.

[7]  M. Rasmussen,et al.  The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary , 2018, Infection.

[8]  M. Rasmussen,et al.  HANDOC: A Handy Score to Determine the Need for Echocardiography in Non-&bgr;-Hemolytic Streptococcal Bacteremia , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  C. Chang,et al.  Risk of infective endocarditis in patients with systemic lupus erythematosus in Taiwan: a nationwide population-based study , 2017, Lupus.

[10]  M. Scalese,et al.  Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. , 2017, Cardiovascular diagnosis and therapy.

[11]  Lemuel R Non,et al.  The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review. , 2017, The Journal of infection.

[12]  P. Søgaard,et al.  Risk Factors of Endocarditis in Patients With Enterococcus faecalis Bacteremia: External Validation of the NOVA Score. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  F. Alla,et al.  The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. , 2016, The Journal of infection.

[14]  E. Hess,et al.  Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  F. Alla,et al.  Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study , 2015, PloS one.

[16]  F. Fernández‐Avilés,et al.  The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  K. Becker,et al.  Coagulase-Negative Staphylococci , 2014, Clinical Microbiology Reviews.

[18]  F. Alla,et al.  Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[20]  Gilbert Habib,et al.  Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. , 2009, Annals of internal medicine.

[21]  V. Fowler,et al.  Coagulase-negative staphylococcal prosthetic valve endocarditis—a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study , 2008, Heart.

[22]  Bruno Hoen,et al.  Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  V. Fowler,et al.  Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. , 2005, The American journal of medicine.

[24]  Gilbert Habib,et al.  Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Jianjun Li,et al.  Structural elucidation of the extracellular and cell-wall teichoic acids of Staphylococcus epidermidis RP62A, a reference biofilm-positive strain. , 2004, Carbohydrate research.

[26]  S. Goldstein,et al.  Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease. , 2001, American heart journal.

[27]  Michael L Wilson,et al.  Relevance of the Number of Positive Bottles in Determining Clinical Significance of Coagulase-Negative Staphylococci in Blood Cultures , 2001, Journal of Clinical Microbiology.

[28]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[30]  A. Morris How best to deal with endocarditis , 2006, Current infectious disease reports.

[31]  M. Höök,et al.  MSCRAMM-mediated adherence of microorganisms to host tissues. , 1994, Annual review of microbiology.